Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Trevor J Bledsoe

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
American Journal of Clinical Oncology|March 10, 2018
Impact of Health Insurance Status on Prostate Cancer Treatment Modality Selection in the United StatesTrevor J Bledsoe, Henry S Park, Charles E Rutter, et al.
International Journal of Radiation Oncology, Biology, Physics|April 9, 2016
Cost-Effectiveness of Surgery, Stereotactic Body Radiation Therapy, and Systemic Therapy for Pulmonary OligometastasesNataniel H Lester-Coll, Charles E Rutter, Trevor J Bledsoe, et al.
Journal of the National Cancer Institute|May 19, 2017
Hypofractionated Radiotherapy for Patients with Early-Stage Glottic Cancer: Patterns of Care and SurvivalTrevor J Bledsoe, Henry S Park, John M Stahl, et al.
Journal of the National Cancer Institute|November 10, 2017
ResponseTrevor J Bledsoe, Henry S Park, John M Stahl, et al.
Brachytherapy|December 25, 2017
Cost-effectiveness of adjuvant intravaginal brachytherapy in high-intermediate risk endometrial carcinomaJohn M Stahl, Shari Damast, Trevor J Bledsoe, et al.
Anticancer Research|March 16, 2016
Split-Course Accelerated Hypofractionated Radiotherapy (SCAHRT): A Safe and Effective Option for Head and Neck Cancer in the Elderly or InfirmTrevor J Bledsoe, Anisha R Noble, Chandana A Reddy, et al.
Radiation Oncology (London, England)|July 11, 2013
Oropharyngeal squamous cell carcinoma with known human papillomavirus status treated with definitive chemoradiotherapy: patterns of failure and toxicity outcomesTrevor J Bledsoe, Anisha R Noble, Grant K Hunter, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
American Journal of Clinical Oncology|March 10, 2018
Impact of Health Insurance Status on Prostate Cancer Treatment Modality Selection in the United StatesTrevor J Bledsoe, Henry S Park, Charles E Rutter, et al.
International Journal of Radiation Oncology, Biology, Physics|April 9, 2016
Cost-Effectiveness of Surgery, Stereotactic Body Radiation Therapy, and Systemic Therapy for Pulmonary OligometastasesNataniel H Lester-Coll, Charles E Rutter, Trevor J Bledsoe, et al.
Journal of the National Cancer Institute|May 19, 2017
Hypofractionated Radiotherapy for Patients with Early-Stage Glottic Cancer: Patterns of Care and SurvivalTrevor J Bledsoe, Henry S Park, John M Stahl, et al.
Journal of the National Cancer Institute|November 10, 2017
ResponseTrevor J Bledsoe, Henry S Park, John M Stahl, et al.
Brachytherapy|December 25, 2017
Cost-effectiveness of adjuvant intravaginal brachytherapy in high-intermediate risk endometrial carcinomaJohn M Stahl, Shari Damast, Trevor J Bledsoe, et al.
Anticancer Research|March 16, 2016
Split-Course Accelerated Hypofractionated Radiotherapy (SCAHRT): A Safe and Effective Option for Head and Neck Cancer in the Elderly or InfirmTrevor J Bledsoe, Anisha R Noble, Chandana A Reddy, et al.
Radiation Oncology (London, England)|July 11, 2013
Oropharyngeal squamous cell carcinoma with known human papillomavirus status treated with definitive chemoradiotherapy: patterns of failure and toxicity outcomesTrevor J Bledsoe, Anisha R Noble, Grant K Hunter, et al.
Pageof 1